IBI363 trials for Melanoma

All IBI363 trials · All Melanoma trials

Phase breakdown

Recruiting trials studying IBI363 for Melanoma

• A Study of IBI363 in Subjects With Advanced Melanoma
  NCT06081920 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• A Study of IBI363 in Subjects with Advanced Solid Malignancies
  NCT06281678 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
  NCT06797297 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 31 locations

Common questions

How many trials study IBI363 for Melanoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.